Global Organ Preservation Solutions 麻豆原创 Growth (Status and Outlook) 2024-2030

Publication ID:

LPI09241382

Publication Date:

September 3, 2024

Pages:

105

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Organ Preservation Solutions market size was valued at US$ 122.5 million in 2023. With growing demand in downstream market, the Organ Preservation Solutions is forecast to a readjusted size of US$ 239.7 million by 2030 with a CAGR of 10.1% during review period.
The research report highlights the growth potential of the global Organ Preservation Solutions market. Organ Preservation Solutions are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Organ Preservation Solutions. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Organ Preservation Solutions market.
Key Features:
The report on Organ Preservation Solutions market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the Organ Preservation Solutions market. It may include historical data, market segmentation by Type (e.g., Viaspan, Custodial), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Organ Preservation Solutions market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Organ Preservation Solutions market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Organ Preservation Solutions industry. This include advancements in Organ Preservation Solutions technology, Organ Preservation Solutions new entrants, Organ Preservation Solutions new investment, and other innovations that are shaping the future of Organ Preservation Solutions.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Organ Preservation Solutions market. It includes factors influencing customer ' purchasing decisions, preferences for Organ Preservation Solutions product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Organ Preservation Solutions market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Organ Preservation Solutions market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Organ Preservation Solutions market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Organ Preservation Solutions industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Organ Preservation Solutions market.
麻豆原创 Segmentation:
Organ Preservation Solutions market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Viaspan
Custodial
siRNA Transplant Solutions
Others
Segmentation by application
Hypothermic Perfusion Preservation (HPP)
Static Cold Storage (SCS)
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Dr. Franz K枚hler Chemie
Teva Pharmaceutical Industries Ltd.
Lifeline Scientific
Bristol-Myers Squibb
BioLife Solutions, Inc.
XVIVO Perfusion AB
ToleroTech, Inc
CryoLife, Inc.
Claris Lifesciences Limited
BioTime, Inc.
21st Century Medicine

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Organ Preservation Solutions 麻豆原创 Size 2019-2030
2.1.2 Organ Preservation Solutions 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Organ Preservation Solutions Segment by Type
2.2.1 Viaspan
2.2.2 Custodial
2.2.3 siRNA Transplant Solutions
2.2.4 Others
2.3 Organ Preservation Solutions 麻豆原创 Size by Type
2.3.1 Organ Preservation Solutions 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Organ Preservation Solutions 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 Organ Preservation Solutions Segment by Application
2.4.1 Hypothermic Perfusion Preservation (HPP)
2.4.2 Static Cold Storage (SCS)
2.4.3 Others
2.5 Organ Preservation Solutions 麻豆原创 Size by Application
2.5.1 Organ Preservation Solutions 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Organ Preservation Solutions 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 Organ Preservation Solutions 麻豆原创 Size by Player
3.1 Organ Preservation Solutions 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global Organ Preservation Solutions Revenue by Players (2019-2024)
3.1.2 Global Organ Preservation Solutions Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Organ Preservation Solutions Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Organ Preservation Solutions by Regions
4.1 Organ Preservation Solutions 麻豆原创 Size by Regions (2019-2024)
4.2 Americas Organ Preservation Solutions 麻豆原创 Size Growth (2019-2024)
4.3 APAC Organ Preservation Solutions 麻豆原创 Size Growth (2019-2024)
4.4 Europe Organ Preservation Solutions 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa Organ Preservation Solutions 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas Organ Preservation Solutions 麻豆原创 Size by Country (2019-2024)
5.2 Americas Organ Preservation Solutions 麻豆原创 Size by Type (2019-2024)
5.3 Americas Organ Preservation Solutions 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Organ Preservation Solutions 麻豆原创 Size by Region (2019-2024)
6.2 APAC Organ Preservation Solutions 麻豆原创 Size by Type (2019-2024)
6.3 APAC Organ Preservation Solutions 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Organ Preservation Solutions by Country (2019-2024)
7.2 Europe Organ Preservation Solutions 麻豆原创 Size by Type (2019-2024)
7.3 Europe Organ Preservation Solutions 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Organ Preservation Solutions by Region (2019-2024)
8.2 Middle East & Africa Organ Preservation Solutions 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa Organ Preservation Solutions 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Organ Preservation Solutions 麻豆原创 Forecast
10.1 Global Organ Preservation Solutions Forecast by Regions (2025-2030)
10.1.1 Global Organ Preservation Solutions Forecast by Regions (2025-2030)
10.1.2 Americas Organ Preservation Solutions Forecast
10.1.3 APAC Organ Preservation Solutions Forecast
10.1.4 Europe Organ Preservation Solutions Forecast
10.1.5 Middle East & Africa Organ Preservation Solutions Forecast
10.2 Americas Organ Preservation Solutions Forecast by Country (2025-2030)
10.2.1 United States Organ Preservation Solutions 麻豆原创 Forecast
10.2.2 Canada Organ Preservation Solutions 麻豆原创 Forecast
10.2.3 Mexico Organ Preservation Solutions 麻豆原创 Forecast
10.2.4 Brazil Organ Preservation Solutions 麻豆原创 Forecast
10.3 APAC Organ Preservation Solutions Forecast by Region (2025-2030)
10.3.1 China Organ Preservation Solutions 麻豆原创 Forecast
10.3.2 Japan Organ Preservation Solutions 麻豆原创 Forecast
10.3.3 Korea Organ Preservation Solutions 麻豆原创 Forecast
10.3.4 Southeast Asia Organ Preservation Solutions 麻豆原创 Forecast
10.3.5 India Organ Preservation Solutions 麻豆原创 Forecast
10.3.6 Australia Organ Preservation Solutions 麻豆原创 Forecast
10.4 Europe Organ Preservation Solutions Forecast by Country (2025-2030)
10.4.1 Germany Organ Preservation Solutions 麻豆原创 Forecast
10.4.2 France Organ Preservation Solutions 麻豆原创 Forecast
10.4.3 UK Organ Preservation Solutions 麻豆原创 Forecast
10.4.4 Italy Organ Preservation Solutions 麻豆原创 Forecast
10.4.5 Russia Organ Preservation Solutions 麻豆原创 Forecast
10.5 Middle East & Africa Organ Preservation Solutions Forecast by Region (2025-2030)
10.5.1 Egypt Organ Preservation Solutions 麻豆原创 Forecast
10.5.2 South Africa Organ Preservation Solutions 麻豆原创 Forecast
10.5.3 Israel Organ Preservation Solutions 麻豆原创 Forecast
10.5.4 Turkey Organ Preservation Solutions 麻豆原创 Forecast
10.5.5 GCC Countries Organ Preservation Solutions 麻豆原创 Forecast
10.6 Global Organ Preservation Solutions Forecast by Type (2025-2030)
10.7 Global Organ Preservation Solutions Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Dr. Franz K枚hler Chemie
11.1.1 Dr. Franz K枚hler Chemie Company Information
11.1.2 Dr. Franz K枚hler Chemie Organ Preservation Solutions Product Offered
11.1.3 Dr. Franz K枚hler Chemie Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Dr. Franz K枚hler Chemie Main Business Overview
11.1.5 Dr. Franz K枚hler Chemie Latest Developments
11.2 Teva Pharmaceutical Industries Ltd.
11.2.1 Teva Pharmaceutical Industries Ltd. Company Information
11.2.2 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Product Offered
11.2.3 Teva Pharmaceutical Industries Ltd. Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.2.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.3 Lifeline Scientific
11.3.1 Lifeline Scientific Company Information
11.3.2 Lifeline Scientific Organ Preservation Solutions Product Offered
11.3.3 Lifeline Scientific Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Lifeline Scientific Main Business Overview
11.3.5 Lifeline Scientific Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Organ Preservation Solutions Product Offered
11.4.3 Bristol-Myers Squibb Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 BioLife Solutions, Inc.
11.5.1 BioLife Solutions, Inc. Company Information
11.5.2 BioLife Solutions, Inc. Organ Preservation Solutions Product Offered
11.5.3 BioLife Solutions, Inc. Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 BioLife Solutions, Inc. Main Business Overview
11.5.5 BioLife Solutions, Inc. Latest Developments
11.6 XVIVO Perfusion AB
11.6.1 XVIVO Perfusion AB Company Information
11.6.2 XVIVO Perfusion AB Organ Preservation Solutions Product Offered
11.6.3 XVIVO Perfusion AB Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 XVIVO Perfusion AB Main Business Overview
11.6.5 XVIVO Perfusion AB Latest Developments
11.7 ToleroTech, Inc
11.7.1 ToleroTech, Inc Company Information
11.7.2 ToleroTech, Inc Organ Preservation Solutions Product Offered
11.7.3 ToleroTech, Inc Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 ToleroTech, Inc Main Business Overview
11.7.5 ToleroTech, Inc Latest Developments
11.8 CryoLife, Inc.
11.8.1 CryoLife, Inc. Company Information
11.8.2 CryoLife, Inc. Organ Preservation Solutions Product Offered
11.8.3 CryoLife, Inc. Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 CryoLife, Inc. Main Business Overview
11.8.5 CryoLife, Inc. Latest Developments
11.9 Claris Lifesciences Limited
11.9.1 Claris Lifesciences Limited Company Information
11.9.2 Claris Lifesciences Limited Organ Preservation Solutions Product Offered
11.9.3 Claris Lifesciences Limited Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Claris Lifesciences Limited Main Business Overview
11.9.5 Claris Lifesciences Limited Latest Developments
11.10 BioTime, Inc.
11.10.1 BioTime, Inc. Company Information
11.10.2 BioTime, Inc. Organ Preservation Solutions Product Offered
11.10.3 BioTime, Inc. Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 BioTime, Inc. Main Business Overview
11.10.5 BioTime, Inc. Latest Developments
11.11 21st Century Medicine
11.11.1 21st Century Medicine Company Information
11.11.2 21st Century Medicine Organ Preservation Solutions Product Offered
11.11.3 21st Century Medicine Organ Preservation Solutions Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 21st Century Medicine Main Business Overview
11.11.5 21st Century Medicine Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.